2018-05-19 - Female
713645
| Adverse reaction report number | 713645 |
| Latest AER version number | 1 |
| Market authorization holder AER number | 600155 |
| Initial received date | 2018-05-19 |
| Latest received date | 2018-07-03 |
| Age | N/A |
| Gender | Female |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | MAH |
| Report outcome | Recovered/resolved |
| Serious report? | Yes |
Reason for seriousness
| Death | |
| Disability | |
| Cogenital anomaly | |
| Life threateting | |
| Hospitalization | |
| Other medically important | Yes |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| OZEMPIC | SOLUTION SUBCUTANEOUS | Suspect | Subcutaneous | 1 every 1 Day(s) | Product used for unknown indication |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Endometrial ablation | |